Build an Inve Case for ALMU → Read the full call → US$ mn · quarterly
Aeluma (ALMU) earnings
Aeluma earnings: last reported Wed, 16 Sep 2026, for the quarter ended Jun 2026.
Aeluma earnings callsAeluma earnings calls (ALMU)
Latest concall · Q2 2026 · call held call held 16 Sept 2026
Aeluma Q4 FY26 — Accelerating AI DataCom Commercialization with Strategic Partnerships and CHIPS Funding
What went well
- Secured a letter of intent for up to $30 million in CHIPS R&D funding to accelerate development and commercialization.
- Closed Q4 FY26 with a strong balance sheet, including $56 million in cash and cash equivalents, up from $37.8 million in Q3 FY26.
- Executed an agreement with Sumitomo Chemical Advanced Technologies to increase wafer production capacity for high-speed photodetectors.
What to watch
- GAAP net loss for Q4 FY26 was $4 million ($0.22 per share), and for FY26 was $9.2 million ($0.52 per share), significantly wider than FY25.
- Adjusted EBITDA for FY26 was negative $5.2 million, compared to positive $186,000 in FY25, driven by increased operating expenses.
Performance −27.7% 1Y
1Y: $17.1 on 29 Sept 2025 → $12.36. High $31.49 (13 May 2026), low $10.73 (9 Apr 2026).
Quarterly results
Q2 FY26: revenue down 55.8%, net profit down 367.7% against the same quarter last year.
| Line item | Q3 FY24 | Q4 FY24 | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 2 | 1 | 1 | 1 +188% | 1 −21% | 1 −3% | 1 −56% |
| EBITDA | -1 | 0 | -2 | 0 | -2 −120% | -2 −635% | -3 −60% | -3 −1198% |
| Net profit | -1 | -3 | 1 | -1 | -1 −105% | -2 +36% | -2 −223% | -4 −368% |
How to read this
US$ million, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Balance sheet
| Year ending | Dec 2020 | Jun 2022 | Jun 2023 | Jun 2024 | Jun 2025 | Jun 2026 |
|---|---|---|---|---|---|---|
| Equity capital | $325 | $1.1K | $1.3K | $1.0K | $2.0K | $2.0K |
| Reserves | -$13.7K | -$3.68M | -$9.06M | -$13.62M | -$16.65M | -$25.80M |
| Total liabilities | $147.9K | $831.1K | $1.05M | $1.57M | $1.51M | $3.73M |
| Fixed assets | — | $987.0K | $1.46M | $1.47M | $1.22M | $1.42M |
| Total assets | $154.2K | $5.93M | $7.16M | $3.84M | $19.41M | $60.66M |
How to read this
As filed on each reporting date, including interim balance sheets. A line the company does not report — deposits for a non-lender, for instance — is left out rather than shown as a row of dashes.
Insider filings
111 filings between Oct 1, 2025 and Sep 21, 2026.
Open market
decisions to buy or sellPurchases
None
No insider bought shares.
Sales
$23.83M
84 sales by 3 insiders
29% filed under a 10b5-1 plan — scheduled in advance, not decided on the day
Compensation
not trading decisions- 8
- Award — granted as compensation
- 1
- Option exercise — converted options into shares
- 2
- Tax withheld — shares kept back by the company to cover tax
Also filed: 16 gifts.
Who traded
open market only| Insider | Bought | Sold | Last filing |
|---|---|---|---|
| Tompkins Mark N. | — | $18.30M | Feb 4, 2026 |
| Klamkin Jonathan | — | $4.26M | Sep 21, 2026 |
| Denbaars Steven | — | $1.27M | Aug 27, 2026 |
Latest filings (50)
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| Sep 21, 2026 | Stewart Christopher P. Chief Financial Officer | Award | 15,886 | $0 |
| Sep 21, 2026 | Klamkin Jonathan Chief Executive Officer | Award 10b5-1 plan | 31,771 | $0 |
| Sep 21, 2026 | Byron Michael Director | Option exercise | 25,000 | $148.3K |
| Sep 21, 2026 | Stewart Christopher P. Chief Financial Officer | Award | 4,042 | $0 |
| Sep 21, 2026 | Klamkin Jonathan Chief Executive Officer | Tax withheld 10b5-1 plan | 4,547 | $61.9K |
| Sep 21, 2026 | Klamkin Jonathan Chief Executive Officer | Award 10b5-1 plan | 12,675 | $0 |
| Sep 21, 2026 | Stewart Christopher P. Chief Financial Officer | Tax withheld | 1,450 | $19.7K |
| Sep 21, 2026 | Klamkin Jonathan Chief Executive Officer | Sale 10b5-1 plan | 100,000 | $1.34M |
| Aug 27, 2026 | Denbaars Steven Director | Sale 10b5-1 plan | 12,500 | $172.7K |
| Aug 26, 2026 | Denbaars Steven Director | Sale 10b5-1 plan | 12,500 | $173.0K |
| Aug 3, 2026 | Klamkin Jonathan Chief Executive Officer | Sale 10b5-1 plan | 4,190 | $68.3K |
| Aug 3, 2026 | Klamkin Jonathan Chief Executive Officer | Gift 10b5-1 plan | 20,000 | $0 |
| Aug 3, 2026 | Klamkin Jonathan Chief Executive Officer | Gift 10b5-1 plan | 20,000 | $0 |
| Aug 3, 2026 | Klamkin Jonathan Chief Executive Officer | Sale 10b5-1 plan | 15,810 | $266.4K |
| Jul 1, 2026 | Klamkin Jonathan Chief Executive Officer | Sale 10b5-1 plan | 19,900 | $419.5K |
| Jul 1, 2026 | Klamkin Jonathan Chief Executive Officer | Gift 10b5-1 plan | 20,000 | $0 |
| Jul 1, 2026 | Klamkin Jonathan Chief Executive Officer | Gift 10b5-1 plan | 20,000 | $0 |
| Jul 1, 2026 | Klamkin Jonathan Chief Executive Officer | Sale 10b5-1 plan | 100 | $2.2K |
| Jun 1, 2026 | Klamkin Jonathan Chief Executive Officer | Sale 10b5-1 plan | 8,200 | $215.2K |
| Jun 1, 2026 | Klamkin Jonathan Chief Executive Officer | Sale 10b5-1 plan | 1,600 | $40.2K |
| Jun 1, 2026 | Klamkin Jonathan Chief Executive Officer | Sale 10b5-1 plan | 7,900 | $192.6K |
| Jun 1, 2026 | Klamkin Jonathan Chief Executive Officer | Sale 10b5-1 plan | 1,400 | $32.6K |
| Jun 1, 2026 | Klamkin Jonathan Chief Executive Officer | Sale 10b5-1 plan | 900 | $20.0K |
| Jun 1, 2026 | Klamkin Jonathan Chief Executive Officer | Gift 10b5-1 plan | 20,000 | $0 |
| Jun 1, 2026 | Klamkin Jonathan Chief Executive Officer | Gift 10b5-1 plan | 20,000 | $0 |
| May 20, 2026 | Denbaars Steven Director | Sale 10b5-1 plan | 942 | $20.1K |
| May 20, 2026 | Denbaars Steven Director | Sale 10b5-1 plan | 11,558 | $235.7K |
| May 19, 2026 | Denbaars Steven Director | Sale 10b5-1 plan | 7,415 | $145.0K |
| May 19, 2026 | Denbaars Steven Director | Sale 10b5-1 plan | 5,085 | $104.8K |
| May 1, 2026 | Klamkin Jonathan Chief Executive Officer | Sale 10b5-1 plan | 15,024 | $377.8K |
| May 1, 2026 | Klamkin Jonathan Chief Executive Officer | Sale 10b5-1 plan | 4,300 | $104.1K |
| May 1, 2026 | Klamkin Jonathan Chief Executive Officer | Gift 10b5-1 plan | 20,000 | $0 |
| May 1, 2026 | Klamkin Jonathan Chief Executive Officer | Gift 10b5-1 plan | 20,000 | $0 |
| May 1, 2026 | Klamkin Jonathan Chief Executive Officer | Sale 10b5-1 plan | 676 | $17.4K |
| Apr 1, 2026 | Klamkin Jonathan Chief Executive Officer | Gift 10b5-1 plan | 20,000 | $0 |
| Apr 1, 2026 | Klamkin Jonathan Chief Executive Officer | Gift 10b5-1 plan | 20,000 | $0 |
| Apr 1, 2026 | Klamkin Jonathan Chief Executive Officer | Sale 10b5-1 plan | 20,000 | $261.9K |
| Mar 4, 2026 | Klamkin Jonathan Chief Executive Officer | Gift 10b5-1 plan | 50,000 | $0 |
| Mar 4, 2026 | Klamkin Jonathan Chief Executive Officer | Gift 10b5-1 plan | 50,000 | $0 |
| Mar 4, 2026 | Klamkin Jonathan Chief Executive Officer | Sale 10b5-1 plan | 28,206 | $501.4K |
| Mar 4, 2026 | Klamkin Jonathan Chief Executive Officer | Sale 10b5-1 plan | 21,794 | $401.2K |
| Feb 26, 2026 | Denbaars Steven Director | Sale 10b5-1 plan | 12,500 | $198.1K |
| Feb 25, 2026 | Denbaars Steven Director | Sale 10b5-1 plan | 12,500 | $219.8K |
| Feb 4, 2026 | Tompkins Mark N. Insider | Sale | 5,956 | $90.1K |
| Feb 4, 2026 | Tompkins Mark N. Insider | Sale | 28,544 | $417.6K |
| Feb 2, 2026 | Tompkins Mark N. 10% owner | Sale | 37,500 | $590.3K |
| Jan 30, 2026 | Tompkins Mark N. 10% owner | Sale | 908 | $15.2K |
| Jan 30, 2026 | Tompkins Mark N. 10% owner | Sale | 24,092 | $382.6K |
| Jan 29, 2026 | Tompkins Mark N. 10% owner | Sale | 5,203 | $89.3K |
| Jan 29, 2026 | Tompkins Mark N. 10% owner | Sale | 27,297 | $457.2K |
Source: SEC Form 4 filings. Form 4 reports transactions, not the cap table — absence of filings says nothing about how much an insider owns, and a quiet window is not a signal.